Get the Stockscreener App
0.097
0.24%
-0.00023
Provectus Biopharmaceuticals Inc Stock (PVCT) Forecast
The Provectus Biopharmaceuticals Inc (PVCT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.4282, representing a +341.45% increase from the current price of $0.097. The highest analyst price target is $0.4487, and the lowest is $0.4077.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PVCT Price Target
Average 0.602
(+520.64% Upside)
Long-term PVCT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Provectus Biopharmaceuticals Inc financial reports and earnings history, Provectus Biopharmaceuticals Inc (PVCT) stock could reach $1.223 by 2030, $2.4059 by 2040 and $5.8077 by 2050. See the projected annual prices until 2050 of the Provectus Biopharmaceuticals Inc stock below:
- Provectus Biopharmaceuticals Inc (PVCT) is expected to reach an average price of $1.8713 in 2035, with a high prediction of $1.8732 and a low estimate of $1.6602. This indicates an $1,829% rise from the last recorded price of $0.097.
- Provectus Biopharmaceuticals Inc (PVCT) stock is projected to chart a bullish course in 2040, with an average price target of $2.3943, representing an $2,368% surge from its current level. The forecast ranges from a conservative $2.0984 to a sky-high $2.4059.
- Our analysts predict Provectus Biopharmaceuticals Inc (PVCT) to jump 2,772% by 2045, soaring from $2.5986 to an average price of $2.7856, potentially reaching $4.7472. While $2.5986 is the low estimate, the potential upside is significant.
- Provectus Biopharmaceuticals Inc (PVCT) stock is expected to climb by 2050, reaching an average of $5.5453, a $5,617% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.8077 and $5.2829, respectively, highlighting the market's uncertainty.
Provectus Biopharmaceuticals Inc Stock (PVCT) Year by Year Forecast
Provectus Biopharmaceuticals Inc Stock (PVCT) Price Forecast for 2025
Provectus Biopharmaceuticals Inc Stock (PVCT) is expected to reach an average price of $0.5344 in 2025, with a high prediction of $0.7018 and a low estimate of $0.3669. This indicates an +450.89% rise from the last recorded price of $0.097.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.4447 | $0.4077 | $0.4487 | +358.43% |
| June, 2025 | $0.4992 | $0.4534 | $0.5002 | +414.66% |
| July, 2025 | $0.5472 | $0.4963 | $0.5472 | +464.09% |
| August, 2025 | $0.6366 | $0.5559 | $0.6366 | +556.30% |
| September, 2025 | $0.4318 | $0.4188 | $0.7018 | +345.20% |
| October, 2025 | $0.4855 | $0.4415 | $0.497 | +400.49% |
| November, 2025 | $0.5332 | $0.4956 | $0.5402 | +449.70% |
| December, 2025 | $0.6028 | $0.5468 | $0.6035 | +521.48% |
Provectus Biopharmaceuticals Inc Stock (PVCT) Price Forecast for 2026
The predicted value for Provectus Biopharmaceuticals Inc (PVCT) in 2026 is set at an average of $0.6808. Estimates vary from a peak of $0.891 to a trough of $0.4707, indicating an +601.88% surge from the present price of $0.097.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.6621 | $0.614 | $0.6661 | +582.60% |
| February, 2026 | $0.7663 | $0.6723 | $0.7963 | +690.00% |
| March, 2026 | $0.5126 | $0.4707 | $0.7945 | +428.50% |
| April, 2026 | $0.5756 | $0.527 | $0.5796 | +493.36% |
| May, 2026 | $0.6331 | $0.5881 | $0.6375 | +552.67% |
| June, 2026 | $0.7129 | $0.646 | $0.7129 | +634.94% |
| July, 2026 | $0.8178 | $0.7255 | $0.8178 | +743.10% |
| August, 2026 | $0.5395 | $0.5226 | $0.891 | +456.20% |
| September, 2026 | $0.6086 | $0.553 | $0.6202 | +527.45% |
| October, 2026 | $0.6718 | $0.6226 | $0.6788 | +592.62% |
| November, 2026 | $0.7608 | $0.6893 | $0.7615 | +684.35% |
| December, 2026 | $0.8356 | $0.7758 | $0.8396 | +761.42% |
Provectus Biopharmaceuticals Inc Stock (PVCT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Provectus Biopharmaceuticals Inc (PVCT) is $0.8743, with a high forecast of $1.1742 and a low forecast of $0.5745. This indicates an +801.38% increase from the last price of $0.097.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.9552 | $0.8496 | $0.9852 | +884.79% |
| February, 2027 | $0.6106 | $0.5745 | $0.9874 | +529.47% |
| March, 2027 | $0.7065 | $0.6256 | $0.7105 | +628.30% |
| April, 2027 | $0.7795 | $0.7229 | $0.7839 | +703.56% |
| May, 2027 | $0.8786 | $0.7962 | $0.8786 | +805.78% |
| June, 2027 | $0.999 | $0.8951 | $0.999 | +929.91% |
| July, 2027 | $0.6289 | $0.6264 | $1.0838 | +548.35% |
| August, 2027 | $0.7318 | $0.6448 | $0.7433 | +654.41% |
| September, 2027 | $0.8105 | $0.7496 | $0.8175 | +735.54% |
| October, 2027 | $0.897 | $0.8318 | $0.9032 | +824.76% |
| November, 2027 | $1.009 | $0.9108 | $1.013 | +940.25% |
| December, 2027 | $1.1442 | $1.0269 | $1.1742 | +1,080% |
Provectus Biopharmaceuticals Inc Stock (PVCT) Price Forecast for 2028
In 2028, Provectus Biopharmaceuticals Inc (PVCT) is projected to reach an average price of $1.0256, with a high projection of $1.373 and a low estimate of $0.6783. This indicates an +957.36% rise from the last price of $0.097.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.7435 | $0.6783 | $1.1802 | +666.46% |
| February, 2028 | $0.8373 | $0.7656 | $0.8413 | +763.24% |
| March, 2028 | $0.9258 | $0.8577 | $0.9302 | +854.46% |
| April, 2028 | $1.0211 | $0.9464 | $1.0211 | +952.69% |
| May, 2028 | $1.1802 | $1.0398 | $1.1802 | +1,117% |
| June, 2028 | $0.7327 | $0.7302 | $1.2766 | +655.36% |
| July, 2028 | $0.8549 | $0.7525 | $0.8665 | +781.37% |
| August, 2028 | $0.9491 | $0.8766 | $0.9561 | +878.46% |
| September, 2028 | $1.0511 | $0.9743 | $1.0573 | +983.63% |
| October, 2028 | $1.1825 | $1.0688 | $1.1865 | +1,119% |
| November, 2028 | $1.3331 | $1.2043 | $1.3631 | +1,274% |
| December, 2028 | $0.8337 | $0.7821 | $1.373 | +759.45% |
Provectus Biopharmaceuticals Inc Stock (PVCT) Price Forecast for 2029
The 2029 price forecast for Provectus Biopharmaceuticals Inc Stock (PVCT) is $1.1999 on average, with a high prediction of $1.5658 and a low estimate of $0.834. This represents an +1,137% increase from the previous price of $0.097.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.9682 | $0.8564 | $0.9722 | +898.18% |
| February, 2029 | $1.0722 | $0.9924 | $1.0766 | +1,005% |
| March, 2029 | $1.183 | $1.0967 | $1.183 | +1,120% |
| April, 2029 | $1.3614 | $1.2056 | $1.3614 | +1,304% |
| May, 2029 | $0.8365 | $0.834 | $1.4694 | +762.37% |
| June, 2029 | $0.9496 | $0.8602 | $0.951 | +878.97% |
| July, 2029 | $1.0877 | $0.9747 | $1.0947 | +1,021% |
| August, 2029 | $1.2052 | $1.1168 | $1.2114 | +1,143% |
| September, 2029 | $1.3279 | $1.2268 | $1.3309 | +1,269% |
| October, 2029 | $1.5221 | $1.352 | $1.5521 | +1,469% |
| November, 2029 | $0.9452 | $0.8859 | $1.5658 | +874.44% |
| December, 2029 | $1.0991 | $0.9718 | $1.1031 | +1,033% |
Provectus Biopharmaceuticals Inc Stock (PVCT) Price Forecast for 2030
Provectus Biopharmaceuticals Inc Stock (PVCT) is expected to reach an average price of $1.3482 in 2030, with a high forecast of $1.7586 and a low forecast of $0.9378. This signifies an +1,290% surge from the last price of $0.097.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2186 | $1.1272 | $1.223 | +1,156% |
| February, 2030 | $1.3448 | $1.2469 | $1.3448 | +1,286% |
| March, 2030 | $1.4836 | $1.3713 | $1.4862 | +1,429% |
| April, 2030 | $0.9403 | $0.9378 | $1.6622 | +869.38% |
| May, 2030 | $1.0689 | $0.9678 | $1.0703 | +1,002% |
| June, 2030 | $1.1975 | $1.0979 | $1.1994 | +1,135% |
| July, 2030 | $1.3593 | $1.2259 | $1.3655 | +1,301% |
| August, 2030 | $1.4975 | $1.3847 | $1.5005 | +1,444% |
| September, 2030 | $1.711 | $1.5254 | $1.741 | +1,664% |
| October, 2030 | $1.0567 | $0.9897 | $1.7586 | +989.43% |
| November, 2030 | $1.1966 | $1.0872 | $1.2001 | +1,134% |
| December, 2030 | $1.3649 | $1.2241 | $1.3693 | +1,307% |
1.88%
1.33%
Cap:
|
Volume (24h):